These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25449343)

  • 1. Characteristics of ventricular fibrillation in relation to cardiac aetiology and shock success: A waveform analysis study in ICD-patients.
    Bonnes JL; Keuper W; Westra SW; Zegers ES; Oostendorp TF; Brouwer MA; Smeets JL
    Resuscitation; 2015 Jan; 86():95-9. PubMed ID: 25449343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular fibrillation waveform characteristics differ according to the presence of a previous myocardial infarction: A surface ECG study in ICD-patients.
    Bonnes JL; Thannhauser J; Hermans MC; Westra SW; Oostendorp TF; Meinsma G; de Boer MJ; Brouwer MA; Smeets JL
    Resuscitation; 2015 Nov; 96():239-45. PubMed ID: 26325098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular fibrillation waveform characteristics of the surface ECG: Impact of the left ventricular diameter and mass.
    Bonnes JL; Thannhauser J; Nas J; Westra SW; Jansen RMG; Meinsma G; de Boer MJ; Smeets JLRM; Keuper W; Brouwer MA
    Resuscitation; 2017 Jun; 115():82-89. PubMed ID: 28363820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized Analysis of the Ventricular Fibrillation Waveform Allows Identification of Myocardial Infarction: A Proof-of-Concept Study for Smart Defibrillator Applications in Cardiac Arrest.
    Thannhauser J; Nas J; Rebergen DJ; Westra SW; Smeets JLRM; Van Royen N; Bonnes JL; Brouwer MA
    J Am Heart Assoc; 2020 Oct; 9(19):e016727. PubMed ID: 33003984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillator therapy in patients with ventricular fibrillation out of hospital cardiac arrest secondary to acute coronary syndrome.
    Madhavan M; Friedman PA; Lennon RJ; Prasad A; White RD; Sriram CS; Gulati R; Gersh BJ
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
    Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
    Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detrended fluctuation analysis predicts successful defibrillation for out-of-hospital ventricular fibrillation cardiac arrest.
    Lin LY; Lo MT; Ko PC; Lin C; Chiang WC; Liu YB; Hu K; Lin JL; Chen WJ; Ma MH
    Resuscitation; 2010 Mar; 81(3):297-301. PubMed ID: 20071067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fibrillation waveform characteristics are different in ischemic heart failure compared with structurally normal hearts.
    Indik JH; Donnerstein RL; Kern KB; Goldman S; Gaballa MA; Berg RA
    Resuscitation; 2006 Jun; 69(3):471-7. PubMed ID: 16600470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation.
    Moubarak JB; Karasik PE; Fletcher RD; Franz MR
    J Am Coll Cardiol; 2000 Feb; 35(2):422-7. PubMed ID: 10676690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the ventricular fibrillation waveform to predict a return of spontaneous circulation and distinguish acute from post myocardial infarction or normal Swine in ventricular fibrillation cardiac arrest.
    Indik JH; Allen D; Gura M; Dameff C; Hilwig RW; Kern KB
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):337-43. PubMed ID: 21493961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the ventricular fibrillation waveform in refibrillation.
    Russell JK; White RD; Crone WE
    Crit Care Med; 2006 Dec; 34(12 Suppl):S432-7. PubMed ID: 17114973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length.
    Zima E; Gergely M; Soós P; Gellér LA; Nemes A; Acsády G; Merkely B
    J Cardiovasc Electrophysiol; 2006 Apr; 17(4):377-81. PubMed ID: 16643358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical period of ventricular fibrillation more susceptible to defibrillation: real-time waveform analysis using a single ECG lead.
    Hsia PW; Frerk S; Allen CA; Wise RM; Cohen NM; Damiano RJ
    Pacing Clin Electrophysiol; 1996 Apr; 19(4 Pt 1):418-30. PubMed ID: 8848389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated vulnerability testing identifies patients with inadequate defibrillation safety margin.
    Birgersdotter-Green U; Ruetz LL; Anand K; Monir G; Abeyratne AI; Bailey JR; Shorofsky SR; Hsia HH; Friedman PA
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1073-80. PubMed ID: 23051838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
    Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
    Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Efficacy and Necessity of Routine Defibrillation Threshold Testing in Patients Undergoing Implantable Cardioverter-Defibrillator (ICD) Implantation.
    Ashino S; Nakai T; Sonoda K; Sasaki N; Kurokawa S; Ikeya Y; Okumura Y; Ohkubo K; Kunimoto S; Watanabe I; Hirayama A
    Int Heart J; 2015; 56(6):618-21. PubMed ID: 26549282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric defibrillation doses often fail to terminate prolonged out-of-hospital ventricular fibrillation in children.
    Berg MD; Samson RA; Meyer RJ; Clark LL; Valenzuela TD; Berg RA
    Resuscitation; 2005 Oct; 67(1):63-7. PubMed ID: 16199288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.